{"url":"https://lda.senate.gov/api/v1/filings/8a56015d-e996-4b96-b341-50173343db3c/","filing_uuid":"8a56015d-e996-4b96-b341-50173343db3c","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/8a56015d-e996-4b96-b341-50173343db3c/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Liesl Sheehan","dt_posted":"2026-07-20T12:48:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1 Beacon Street","registrant_address_2":"Suite 16300","registrant_different_address":false,"registrant_city":"Boston","registrant_state":"MA","registrant_zip":"02108","registrant":{"id":90250,"url":"https://lda.senate.gov/api/v1/registrants/90250/","house_registrant_id":30006,"name":"TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES)","description":"government relations","address_1":"1 Beacon Street","address_2":"Suite 16300","address_3":null,"address_4":null,"city":"Boston","state":"MA","state_display":"Massachusetts","zip":"02108","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"LIESL SHEEHAN","contact_telephone":"+1 617-236-5830","dt_updated":"2026-07-20T13:35:23.865190-04:00"},"client":{"id":174450,"url":"https://lda.senate.gov/api/v1/clients/174450/","client_id":1003694,"name":"PROLACTA BIOSCIENCE, INC.","general_description":"Standardized human milk-based nutritional products for premature infants in the NICU","client_government_entity":false,"client_self_select":null,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-01-01"},"lobbying_activities":[{"general_issue_code":"FOO","general_issue_code_display":"Food Industry (safety, labeling, etc.)","description":"FDA Appropriations; FDA industry oversight.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":50352,"prefix":null,"prefix_display":null,"first_name":"LIESL","nickname":null,"middle_name":null,"last_name":"GREBENSTEIN SHEEHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149843,"prefix":null,"prefix_display":null,"first_name":"MALIA","nickname":null,"middle_name":null,"last_name":"CHING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139238,"prefix":"ms","prefix_display":"MS.","first_name":"ALEXANDRA","nickname":null,"middle_name":null,"last_name":"EBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154479,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRA","nickname":null,"middle_name":null,"last_name":"KARABATSOS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Appropriations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":50352,"prefix":null,"prefix_display":null,"first_name":"LIESL","nickname":null,"middle_name":null,"last_name":"GREBENSTEIN SHEEHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149843,"prefix":null,"prefix_display":null,"first_name":"MALIA","nickname":null,"middle_name":null,"last_name":"CHING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139238,"prefix":"ms","prefix_display":"MS.","first_name":"ALEXANDRA","nickname":null,"middle_name":null,"last_name":"EBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154479,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRA","nickname":null,"middle_name":null,"last_name":"KARABATSOS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Advocacy in support of safety in human milk market. Access to Donor Milk Act. Infant formula and HR 2300.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":50352,"prefix":null,"prefix_display":null,"first_name":"LIESL","nickname":null,"middle_name":null,"last_name":"GREBENSTEIN SHEEHAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149843,"prefix":null,"prefix_display":null,"first_name":"MALIA","nickname":null,"middle_name":null,"last_name":"CHING","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139238,"prefix":"ms","prefix_display":"MS.","first_name":"ALEXANDRA","nickname":null,"middle_name":null,"last_name":"EBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":154479,"prefix":null,"prefix_display":null,"first_name":"ALEXANDRA","nickname":null,"middle_name":null,"last_name":"KARABATSOS","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}